Repligen (NASDAQ:RGEN) Earns Overweight Rating from Analysts at Wells Fargo & Company
Wells Fargo & Company started coverage on shares of Repligen (NASDAQ:RGEN – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $180.00 price target on the biotechnology company’s stock. Several other equities analysts have also recently issued reports on RGEN. Benchmark restated a hold rating […]
More Stories
2 Dead, 8 in Critical Condition in Brown University Shooting; Suspect at Large
By Ryan Morgan Two people are dead and eight others are hospitalized in critical condition following a shooting on the...
As Battle Group Off Venezuela Awaits Orders, a New Commander Takes the Helm
By John Haughey DORAL, Fla.—The largest United States naval force to prowl the Caribbean in decades is steaming off Venezuela’s...
2 US Army Soldiers, Civilian Interpreter Killed by ISIS Gunman in Syria
By Tom Ozimek Two U.S. Army soldiers and a civilian interpreter were killed, and three others were injured in an...
ICE Announces Arrest of 400 Illegal Immigrants in Minnesota
By Naveen Athrappully More than 400 illegal immigrants have been arrested in Minnesota by Immigration and Customs Enforcement (ICE) as...
Underlying Factors in Minnesota Welfare Fraud: Readers Weigh In
By Lawrence Wilson Minnesota is now the center of a major pandemic-era welfare-fraud investigation that has outraged taxpayers nationwide. Much...
With More Nations Than Ever, World Cup 2026 Brings a Security Challenge
By Chris Summers The 2026 World Cup soccer tournament will present a major security challenge for its main host, the...